More stories
Insurance Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp. Discover what this breakthrough could mean for pain management and claims strategies.
Workers' Comp
Article
The Implications of Trump's Health Care Executive Order for Workers' Compensation and Auto Insurers
Explore the immediate effects of President Trump's 2025 health care executive order on workers' compensation and auto insurers, including rising drug costs and supply chain disruptions.
WorkcompWire
In the News
Enlyte Releases 2025 Drug Trends Report, Part 1: Opioids Down, Migraine Meds Up
Enlyte's new Drug Trends Report shows 7.8% drop in opioid use while migraine medications rise 8.7% in workers' comp claims during 2024.
Workers' Comp
Article
Ask The Pharmacist: Bird Flu and Its Growing Impact on Public Health
Bird flu, or avian influenza, is an emerging public health and industry concern across North America. While the virus primarily affects birds, it can occasionally spread to humans—raising important questions around occupational exposure and public health safety.
Business Insurance
In the News
Migraine meds on rise in comp despite overall drop in scripts
Enlyte report shows migraine medications gaining popularity in workers' comp while opioid prescriptions continue downward trend in 2024.
Business Hangout
In the News
Drug Use Insights: Migraines Rise While Opioids Decline
New Enlyte report reveals shifting trends: migraine medications up 8.7%, while opioid prescriptions decline 7.8% in workers' comp claims for 2024.